Published by mark itwired
Posted on September 16, 2021
8 min readLast updated: January 20, 2026
Driven by governments’ efforts towards development of centralized and organized tracking systems, the global demand for counterfeit drug detection devices will see 1.5X expansion over the decade-old forecast period (2019 – 2029). Increasing surveillance practices of the Drug Enforcement Agency and Customs and Border Protection to conduct screening activities on medicines and health products will remain pivotal in the market build-up.
Governments also continue to conduct awareness about fake drugs, which would be among the key factors limiting supply of counterfeit drugs. This, in turn, will drive the growth of counterfeit drug detection devices market. For an instance, the European Union recently introduced falsified Medicine Directive (FMD) to address threats of counterfeit medicines impacting entire supply chain.
Greater emphasis of regulatory bodies on development of regulations such as FMD in Europe to reduce counterfeit drug supply will be offering ample growth opportunities to market players in the near future.
Request For Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7838
Some of the key players offering counterfeit drug detection devices include Spectris, Thermo Fisher Scientific, Inc, Olympus Corporation, Metrohm AG, and Rigaku Corporation. Top four companies (Thermofisher Scientific Inc, Olympus Corporation, Spectris, and Rigaku Corporation) currently contribute nearly 60% share in the market revenues.
Some of the prominent companies are focused towards the development of innovative track and trace technology such as Trutag, while others continue to dedicate focus to geographical expansion. Product portfolio through acquisition of smaller players would be one of the key strategies adopted by market leaders.
Besides the development of on-drug tracking technologies, new methodologies such as paper-based test cards are being developed to identify counterfeit drugs at the purchase point. However, these paper-based test cards still require further testing before their deployment in the market.
The counterfeit drug detection device market, a new study from Future Market Insights, provides unparalleled insights on evolution of the drug detection devices during 2014 – 2018 and presents demand projections during 2019 – 2029 on the basis of product category (counterfeit chemical composition detection devices and counterfeit packaging & labelling detection devices), modality (portable devices, handheld devices and benchtop devices), and end user (pharmaceutical companies, drug testing laboratories, and research organizations) across seven prominent regions.
Download Report TOC @ https://www.futuremarketinsights.com/reports/counterfeit-drug-detection-device-market/table-of-content
1.1. Global Market Outlook
1.2. Market Dynamics
1.3. Analysis and Recommendations
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
4.1. Global Pharmaceutical Industry Outlook
4.2. Classification of Counterfeit Drugs
4.3. Falsified Medicines Directive (FMD)
4.4. List of Products
4.5. Product Quality Attributes and Assessments
4.6. Regulatory Scenario
4.7. Current Surveillance Practices and Trends
4.8. Product Adoption Analysis
5.1. Regional Pricing Analysis By Product Type
5.2. Pricing Break-up
5.2.1. Manufacturer Level Pricing
5.2.2. Distributor Level Pricing
5.3. Global Average Pricing Analysis Benchmark
6.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
6.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7.1. Macro-Economic Factors
7.1.1. Rising Population
7.1.2. Increasing number of Pharmaceuticals
7.1.3. Global GDP Outlook
The post Counterfeit Drug Detection Device Market Detail Research, Future Scope, Opportunity Assessment 2029 first appeared on Market Research Blog.
Driven by governments’ efforts towards development of centralized and organized tracking systems, the global demand for counterfeit drug detection devices will see 1.5X expansion over the decade-old forecast period (2019 – 2029). Increasing surveillance practices of the Drug Enforcement Agency and Customs and Border Protection to conduct screening activities on medicines and health products will remain pivotal in the market build-up.
Governments also continue to conduct awareness about fake drugs, which would be among the key factors limiting supply of counterfeit drugs. This, in turn, will drive the growth of counterfeit drug detection devices market. For an instance, the European Union recently introduced falsified Medicine Directive (FMD) to address threats of counterfeit medicines impacting entire supply chain.
Greater emphasis of regulatory bodies on development of regulations such as FMD in Europe to reduce counterfeit drug supply will be offering ample growth opportunities to market players in the near future.
Request For Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7838
Some of the key players offering counterfeit drug detection devices include Spectris, Thermo Fisher Scientific, Inc, Olympus Corporation, Metrohm AG, and Rigaku Corporation. Top four companies (Thermofisher Scientific Inc, Olympus Corporation, Spectris, and Rigaku Corporation) currently contribute nearly 60% share in the market revenues.
Some of the prominent companies are focused towards the development of innovative track and trace technology such as Trutag, while others continue to dedicate focus to geographical expansion. Product portfolio through acquisition of smaller players would be one of the key strategies adopted by market leaders.
Besides the development of on-drug tracking technologies, new methodologies such as paper-based test cards are being developed to identify counterfeit drugs at the purchase point. However, these paper-based test cards still require further testing before their deployment in the market.
The counterfeit drug detection device market, a new study from Future Market Insights, provides unparalleled insights on evolution of the drug detection devices during 2014 – 2018 and presents demand projections during 2019 – 2029 on the basis of product category (counterfeit chemical composition detection devices and counterfeit packaging & labelling detection devices), modality (portable devices, handheld devices and benchtop devices), and end user (pharmaceutical companies, drug testing laboratories, and research organizations) across seven prominent regions.
Download Report TOC @ https://www.futuremarketinsights.com/reports/counterfeit-drug-detection-device-market/table-of-content
1.1. Global Market Outlook
1.2. Market Dynamics
1.3. Analysis and Recommendations
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
4.1. Global Pharmaceutical Industry Outlook
4.2. Classification of Counterfeit Drugs
4.3. Falsified Medicines Directive (FMD)
4.4. List of Products
4.5. Product Quality Attributes and Assessments
4.6. Regulatory Scenario
4.7. Current Surveillance Practices and Trends
4.8. Product Adoption Analysis
5.1. Regional Pricing Analysis By Product Type
5.2. Pricing Break-up
5.2.1. Manufacturer Level Pricing
5.2.2. Distributor Level Pricing
5.3. Global Average Pricing Analysis Benchmark
6.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
6.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7.1. Macro-Economic Factors
7.1.1. Rising Population
7.1.2. Increasing number of Pharmaceuticals
7.1.3. Global GDP Outlook
The post Counterfeit Drug Detection Device Market Detail Research, Future Scope, Opportunity Assessment 2029 first appeared on Market Research Blog.
Explore more articles in the Research Reports category
